← SynDRA
ML348
SynDRA canonical compound SYN0575950 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | LYPLA1 |
|---|
| Mechanism of action | lysophospholipase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- RefChem:1089769
- MFCD05123530
- GNF-Pf-1127
- SMR000033454
- ML-348
- SR-01000595170
- OXKNHBBDOIMFFQ-UHFFFAOYSA-N
- MLS000047443
- MLS004819989
- C18H17ClF3N3O3
- orb1304201
- SCHEMBL25692822
- GTPL13412
- BDBM207991
- GLXC-04151
- HMS2296O04
- EX-A1091
- ZKB71386
- s6564
- STL419865
- AKOS002133531
- ML-348(ML348)
- CS-5993
- EBC-373055
- ML-348(ML348)?
- AC-35406
- AS-16715
- ST082657
- DB-244112
- HY-100736
- SR-01000595170-1
- SR-01000595170-3
- SR-01000595170-4
- SR-01000595170-5
Look up ML348 in the interactive SynDRA portal →